Jeffrey M. Farma - Concepedia

Author

Jeffrey M. Farma

Also Known As

Anderson, Matilda, Farma J, Farma, Jeffrey M, Hela Saidi, Henry R. Govekar, J Farma, J. Farma, J. M. Farma, J.M. Farma, Jeffrey M. Farma

230

Publications

6.1K

Citations

H-Index

Concepts

All Affiliations

Fox Chase Cancer Center Moffitt Cancer Center Memorial Sloan Kettering Cancer Center The University of Texas MD Anderson Cancer Center Duke University

About

Jeffrey M. Farma is an author at Fox Chase Cancer Center specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	34	1.8K
2	Health Sciences	8	8	762
3	Arts	1	1	26
4	Engineering	1	1	61
5	Public Health	1	1	36

Jeffrey M. Farma

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma Mark B. Faries, John F. Thompson, Alistair J. Cochran, New England Journal of Medicine	2017	1.4K
Preoperative Treatment of Locally Advanced Rectal Cancer Deborah Schrag, Qian Shi, Martin R. Weiser, New England Journal of Medicine	2023	387
Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology Christopher K. Bichakjian, Thomas Olencki, Sumaira Z. Aasi, Journal of the National Comprehensive Cancer Network Surgical OncologyCancer ManagementPathologyDermatologyTumor Biology	2018	313
PET/CT Fusion Scan Enhances CT Staging in Patients with Pancreatic Neoplasms Jeffrey M. Farma, Alfredo A. Santillan, Marcovalerio Melis, Annals of Surgical Oncology Pancreatic CancerMedical ImagingMedicinePet-mriPancreatic Neoplasms	2008	181
Dermatofibrosarcoma Protuberans: How Wide Should We Resect? Jeffrey M. Farma, John B. Ammori, Jonathan S. Zager, Annals of Surgical Oncology Dermatofibrosarcoma ProtuberansSurgical PathologyHistopathologyPathologyClinical Dermatology	2010	159
NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022 Chrysalyne D. Schmults, Rachel Blitzblau, Sumaira Z. Aasi, Journal of the National Comprehensive Cancer Network Nccn Guidelines® InsightsSurgical OncologySquamous Cell CarcinomaCancer ManagementDermatology	2021	137
Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signatures Niklas K. Finnberg, Prashanth Gokare, Avital Lev, Oncotarget	2017	126
Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048) Ethan Basch, Amylou C. Dueck, Sandra A. Mitchell, Journal of Clinical Oncology	2023	121
Interleukin-1β induced vascular permeability is dependent on induction of endothelial Tissue Factor (TF) activity Markus Puhlmann, David M. Weinreich, Jeffrey M. Farma, Journal of Translational Medicine	2005	117
Basal Cell Skin Cancer, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology Chrysalyne D. Schmults, Rachel Blitzblau, Sumaira Z. Aasi, Journal of the National Comprehensive Cancer Network Tumor BiologySurgical OncologySkin CancerMedicinePhotocarcinogenesis	2023	100

Page 1